Skip to content

Clinical trials

Phase 3 Lung Diseases trials in the United Kingdom

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lung Diseases Phase: Phase 3 Country / region: United Kingdom Clear all

23 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20051
20092
20131
20143
20151
20162
20171
20181
20193
20201
20221
20232
20242
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed12
Recruiting5
Terminated3
Active, not recruiting2
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca7
United Therapeutics2
Vertex Pharmaceuticals Incorporated2
Bayer1
Daiichi Sankyo1
Eli Lilly and Company1
GlaxoSmithKline1
Hoffmann-La Roche1
Mallinckrodt1
Novartis Pharmaceuticals1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lung Diseases23
Respiratory Tract Diseases15
Bronchial Diseases7
Carcinoma, Non-Small-Cell Lung6
Lung Diseases, Obstructive6
Asthma5
Lung Neoplasms5
Pathologic Processes4
Connective Tissue Diseases3
Neoplasms3

Trials

Showing 1 to 23 of 23. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.